Prostate Cancer
📧 Sign up to get email alerts when something new happens for Prostate Cancer.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2021-04-05FDA Approved: ABIRATERONE — Supplemental Application (BluePoint Laboratories)
FDA approved a supplemental application for ABIRATERONE ACETATE (BluePoint Laboratories) under ANDA 210686.
-
FDA approval · 2021-04-05FDA Approved: ABIRATERONE ACETATE — Supplemental Application (NORTHSTAR RX LLC)
FDA approved a supplemental application for abiraterone acetate (generic version). The product is manufactured by NorthStar RX LLC.
-
CLINICAL_TRIALS trial_result · 2021-04-01Clinical Trial Update: Telaglenastat + Talazoparib In Prostate Cancer [Phase 2]
Phase 2 clinical trial update evaluating telaglenastat in combination with talazoparib for metastatic prostate cancer.
-
CLINICAL_TRIALS trial_result · 2021-03-29Clinical Trial Update: Apalutamide in Treating Patients With Prostate Cancer Who Are in Active Surveillance [Phase 2]
Phase 2 trial update on apalutamide for prostate cancer patients under active surveillance has been terminated with results posted.
-
CLINICAL_TRIALS trial_result · 2021-03-25Clinical Trial Update: Docetaxel, Prednisone, and Pasireotide in Treating Patients With Metastatic Hormone-Resistant Prostate Cancer [Phase 1, Phase 2]
Phase 1/2 clinical trial evaluating docetaxel, prednisone, and pasireotide in metastatic hormone-resistant prostate cancer has completed wit…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2021-03-25Clinical Trial Update: A Study to Evaluate the Safety and Efficacy of Relugolix in Men With Advanced Prostate Cancer [Phase 3]
Phase 3 trial update evaluating the safety and efficacy of relugolix in men with advanced prostate cancer has completed and results were pos…
-
CLINICAL_TRIALS trial_result · 2021-03-25Clinical Trial Update: Adjuvant Treatment of Prostate Cancer With Docetaxel or Not After Radical Radiotherapy [Phase 3]
Phase 3 trial evaluating adjuvant docetaxel after radical radiotherapy in prostate cancer; status not specified.
-
CLINICAL_TRIALS trial_result · 2021-03-23Clinical Trial Update: Study of Erectile Dysfunction, Urinary Incontinence and Related QoL After TOOKAD® VTP for Low Risk Prostate Cancer [Phase 4]
Phase 4 trial update on TOOKAD VTP for low risk prostate cancer; study terminated.
-
CLINICAL_TRIALS trial_result · 2021-03-23Clinical Trial Update: Cabozantinib-S-Malate in Treating Patients With Hormone-Resistant Metastatic Prostate Cancer [NA]
Completed clinical trial evaluating cabozantinib-s-malate in hormone-resistant metastatic prostate cancer; results posted in 2021.
-
CLINICAL_TRIALS trial_result · 2021-03-23Clinical Trial Update: Pantoprazole and Docetaxel for Men With Metastatic Castration-Resistant Prostate Cancer [Phase 2]
Phase 2 trial update evaluating pantoprazole in combination with docetaxel for metastatic castration-resistant prostate cancer has completed…
-
CLINICAL_TRIALS trial_result · 2021-03-19Clinical Trial Update: SpaceOAR System Pivotal Study [Phase 3]
Pivotal Phase 3 trial update for SpaceOAR System in prostate cancer; study completed with results posted in 2021.
-
CLINICAL_TRIALS trial_result · 2021-03-12Clinical Trial Update: Docetaxel/Prednisone Versus Docetaxel/Prednisone and Enzalutamide in Castration-Resistant Prostate Cancer [Phase 2]
Phase 2 trial comparing docetaxel/prednisone with and without enzalutamide in castration-resistant prostate cancer; study terminated with re…
-
CLINICAL_TRIALS trial_result · 2021-03-05Clinical Trial Update: PD-L1 Inhibition as ChecKpoint Immunotherapy for NeuroEndocrine Phenotype Prostate Cancer [Phase 2]
Phase 2 trial updating PD-L1 inhibition as checkpoint immunotherapy for neuroendocrine phenotype prostate cancer completed with results post…
-
CLINICAL_TRIALS trial_result · 2021-03-02Clinical Trial Update: Prostate Radiation Therapy or Short-Term Androgen Deprivation Therapy and Pelvic Lymph Node Radiation Therapy With or Without Prostate Radiation Therapy in Treating Patients With a Rising Prostate Specific Antigen (PSA) After Surgery for Prostate Cancer [Phase 3]
Phase 3 trial evaluating radiation therapy strategies with or without short-term androgen deprivation therapy for men with a rising PSA afte…
-
CLINICAL_TRIALS trial_result · 2021-03-02Clinical Trial Update: A Study of SHR3680 in Treating Patients With Hormone Sensitive Prostate Cancer [Phase 3]
Phase 3 study update for SHR3680 in hormone-sensitive prostate cancer.
-
CLINICAL_TRIALS trial_result · 2021-02-25Clinical Trial Update: Genomics in Michigan Impacting Observation or Radiation [NA]
A completed clinical trial from the University of Michigan Rogel Cancer Center assessing genomics-guided observation or radiation strategies…
-
CLINICAL_TRIALS trial_result · 2021-02-25Clinical Trial Update: Intensity-Modulated Radiation Therapy With or Without Decreased Radiation Dose to Erectile Tissue in Treating Patients With Stage II Prostate Cancer [NA]
A completed clinical trial comparing intensity-modulated radiation therapy with and without decreased radiation dose to erectile tissue in s…
-
CLINICAL_TRIALS research · 2021-02-23Clinical Trial Update: KV-CBCT and Ultrasound Imaging in Guiding Radiation Therapy in Patients With Prostate, Liver, or Pancreatic Cancer [NA]
Clinical trial update on KV-CBCT and ultrasound imaging to guide radiation therapy in adult liver cancer, pancreatic cancer, and prostate ca…
-
CLINICAL_TRIALS trial_result · 2021-02-21Clinical Trial Update: Hormone Therapy and Docetaxel or Hormone Therapy Alone in Treating Patients With Metastatic Prostate Cancer [Phase 3]
Phase 3 trial evaluating hormone therapy with or without docetaxel in metastatic prostate cancer has completed.
-
CLINICAL_TRIALS trial_result · 2021-02-21Clinical Trial Update: Triptorelin, Flutamide, and External-Beam Radiation Therapy or External-Beam Radiation Therapy Alone in Treating Patients With Stage II or Stage III Prostate Cancer [Phase 3]
Phase 3 trial comparing triptorelin with/without flutamide plus external-beam radiation therapy versus external-beam radiation therapy alone…
-
CLINICAL_TRIALS trial_result · 2021-02-21Clinical Trial Update: Beta Adrenergic Receptor Blockade as a Novel Therapy for Patients With Adenocarcinoma of the Prostate [Phase 2]
Phase 2 clinical trial investigating beta-adrenergic receptor blockade as a novel therapy for prostate cancer.
-
CLINICAL_TRIALS trial_result · 2021-02-21Clinical Trial Update: Comparison of Radiation Therapy Regimens in Treating Patients With Localized Prostate Cancer [Phase 3]
Phase 3 clinical trial comparing radiation therapy regimens for localized prostate cancer has completed.
-
CLINICAL_TRIALS trial_result · 2021-02-21Clinical Trial Update: High Resolution PET-MRI Before Prostate Cancer HIFU [Phase 2]
Phase 2 trial update evaluating high-resolution PET-MRI before HIFU treatment for prostate cancer has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2021-02-21Clinical Trial Update: A Study of SHR3680 in Combination With Docetaxel in the Treatment of mCRPC [Phase 2]
Phase 2 trial update of SHR3680 in combination with docetaxel for metastatic prostate cancer (mCRPC).
-
CLINICAL_TRIALS trial_result · 2021-02-18Clinical Trial Update: Dovitinib(TKI258) in Patients With Castration-resistant Prostate Cancer [Phase 2]
Phase 2 clinical trial of Dovitinib (TKI258) in patients with castration-resistant prostate cancer has completed.